Primary HIV infection

International Journal of STD and AIDS

Volumn 13, Issue 2, 2002, Pages 71-78

  Apoola, A ^a   Ahmad, S ^b   Radcliffe, K ^a  

^a Whittall Street Clinic ^*  (United Kingdom)

^b ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

Acute disease; Diagnosis; Drug therapy; HIV infections; Seroconversion

Indexed keywords

DISEASE SEVERITY; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETHARGY; LYMPHADENOPATHY; MALAISE; PHARYNGITIS; PRIORITY JOURNAL; RASH; REVIEW; SEROCONVERSION; SERODIAGNOSIS; THRUSH; ULCER; VIRUS LOAD;

ACUTE DISEASE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS;

EID: 0036167552     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462021924613     Document Type: Review

References (89)

1. Needlestick transmission of HTLV-III from a patient infected in Africa
2. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion
3. Clinical and epidemiologic features of primary HIV infection
4. Characterization of the acute clinical illness associated with human immunodeficiency virus infection
5. Clinical course of primary HIV infection: Consequences for subsequent infection
6. Risk of developing AIDS after primary acute HIV-1 infection
7. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study
8. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness
9. Symptomatic primary infection due to human immunodefiency virus type 1: Review of 31 cases
10. Severe primary HIV-1 infection among black persons in Barbados
11. Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia
12. Primary HIV infection: Host responses and intervention strategies
13. Mucocutaneous manifestations in 22 consecutive cases of primary HIV-1 infection
14. Histopathology of acute human immunodeficiency virus exanthema
15. Immunohistology of the skin rash associated with acute HIV infection
16. Primary human T-lymphotropic virus type III infection
17. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash
18. Acute HTLV-III infection with roseola-like rash
19. Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome
20. Severe illness associated with appearance of antibody to human immunodeficiency virus in an African
21. Primary human immunodeficiency virus infection mimicking syphilis
22. Severe clinical manifestations of primary HIV infection
23. Acute myelopathy associated with primary infection with human immunodeficiency virus
24. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome
25. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III
26. HTLV-III and vacuolar myelopathy
27. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
28. Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention
29. Acute infection with human immunodeficiency virus associated with facial nerve palsy and neuralgia
30. The neurological features of early and 'latent' human immunodeficiency virus infection
31. Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection
32. Acute HIV infection presenting with painful swallowing and esophageal ulcers
33. Candida esophagitis associated with acute human immunodeficiency virus infection
34. Hepatitis associated with primary HIV infection
35. A spotted fever and melaena: Acute HIV seroconversion
36. Acute rhabdomyolysis coincident with primary HIV-1 infection
37. Acute human immunodeficiency virus infection temporally associated with rhabdomyolysis, acute renal failure, and nephrosis
38. Acute rhabdomyolysis in patients infected by human immunodeficiency virus
39. Primary HIV-I infection associated with pneumonitis
40. Lymphocytic alveolitis in primary HIV infection
41. Acute HIV seroconversion and pneumonitis
42. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft
43. Heparine-like anticoagulant vasculitis associated with severe primary infection by HIV
44. Acute exanthem and pancreatic panniculitis in a patient with primary HIV infection and haemophagocytic syndrome
45. Acute pancreatitis complicating primary HIV-1 infection
46. Pneumocystis carinii pneumonia during primary HIV-1 infection
47. Prolonged cryptosporidiosis during primary HIV infection
48. False positive Paul-Bunnell test in HIV seroconversion
49. Antiplatelet antibodies in primary infection by human immunodeficiency virus
50. The Vancouver Lymphadenopathy-AIDS Study: 7. Clinical and laboratory features of 87 cases of primary HIV infection
51. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: A case series
52. Advantage of combined HIV antibody and p24 antigen assays to 3rd-generation HIV assays in the diagnosis of HIV infection
53. Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 × 10(6)/1, AIDS, and death from AIDS?
54. Predictors of rapid progression to AIDS in HIV-1 seroconverters
55. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: Relation to CD4 cell count and clinical course of primary infection
56. Incubation and duration of specific symptoms at acute retroviral syndrome (ARS) are independent predictors of progression to AIDS
57. Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression
58. Severity and prognosis of acute human immunodeficiency virus type 1 illness: A dose-response relationship
59. Model-based optimization of infectivity parameters: A study of the early epidemic in San Francisco
60. Role of the primary infection in epidemics of HIV infection in gay cohorts
61. Biologic correlates of infectiousness in semen in primary HIV-1 infection
62. Sexual transmission can precede symptoms in primary HIV-1 Infection
63. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
64. Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidine
65. Retroviruses and mouse embryos: A rapid model for neurovirulence and transplacental antiviral therapy
66. 3′-Azido-3′-deoxythymidine in feline leukemia virus-infected cats: A model for therapy and prophylaxis of AIDS
67. A controlled trial of zidovudine in primary human immunodefidency virus infection
68. Primary HIV infection: Follow-up of patients initially randomized to zidovudine or placebo
69. Zidovudine in the management of primary HIV-1 infection
70. Combined therapy with zidovudine and L-697,661 in primary HIV infection
71. Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection
72. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses
73. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: Partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia
74. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir
75. Control of HIV despite the discontinuation of antiretroviral therapy
76. Successful interuption of antiretroviral therapy (ARVT) in patients with primary HIV infection (HIV)
77. Immune control of HIV-1 after early treatment of acute infection
78. Effects of therapy delay on virologic failure in early HIV
79. Treatment of primary HIV infection: Efficacy, tolerance and predictors of response
80. Early occurrence of lipodystrophy in HIV-1 infected patients treated during primary infection
81. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
82. Transmission of antiretroviral-drug-resistant HIV-1 variants
83. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
84. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine
85. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
86. Antiretroviral drug susceptibility and response to initial therapy among recently HIV-infected subjects in North America
87. Prevalence of drug resistant HIV-1 variants in newly infected individuals during 1999-2000
88. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
89. Viral load and heterosexual transmission of human immunodeficiency virus type 1